Daan Gene Co., Ltd. (SHE:002030)
5.37
+0.03 (0.56%)
Oct 23, 2026, 3:04 PM CST
Daan Gene Revenue
Daan Gene had revenue of 178.39M CNY in the quarter ending June 30, 2026, with 5.28% growth. This brings the company's total for the last twelve months to 746.91M, down -5.60% year-over-year. In the year 2025, Daan Gene had annual revenue of 757.66M, down -11.18%. That makes Daan Gene the 21,793rd largest company in the world by revenue and 3,989th in China.
Revenue (ttm)
746.91M
Revenue Growth
-5.60%
P/S Ratio
10.09
Revenue / Employee
495.96K
Employees
1,506
Market Cap
7.54B
Revenue by Segment
- Biological Products and Related Business 727.61M 96.0%
- Financial Business 30.38M 4.0%
Fiscal year ended Dec 31, 2025 See the full Daan Gene breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 757.66M | -95.36M | -11.18% |
| Dec 31, 2024 | 853.02M | -327.87M | -27.76% |
| Jan 1, 2024 | 1.18B | -10.87B | -90.20% |
| Jan 1, 2023 | 12.05B | 4.38B | 57.17% |
| Jan 1, 2022 | 7.66B | 2.32B | 43.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novogene | 2.28B |
| Aurisco Pharmaceutical | 1.70B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.69B |
| Jiangxi Fushine Pharmaceutical | 1.56B |
| Vcanbio Cell & Gene Engineering Corp., | 1.40B |
| Liaoning Chengda Biotechnology | 1.36B |
| Chengdu Easton Biopharmaceuticals | 1.34B |
| Bio-Thera Solutions | 1.01B |